» Articles » PMID: 38922377

Prevalence and Clinical Implications of Bloodstream Infections in Intensive Care Patients with or Without Burn Injury: a Retrospective Cohort Study

Abstract

Purpose: Severe burn injuries are often accompanied by infections and associated with high morbidity and mortality. This study aimed to compare the prevalence and clinical impact of bacteremia between patients receiving intensive care with and without burns.

Methods: This single-center retrospective cohort study at the University Hospital Vienna, Austria, analyzed blood cultures from intensive care unit (ICU) patients with and without burns (2012-2022) to assess the prevalence of bacteremia, the associated pathogen distribution and the 60-day all-cause mortality.

Results: In 1170 ICU patients, 303 with burns and 867 without, the prevalence of bacteremia was similar among patients with at least one blood culture (31/157 [19.7%] versus 44/213 [20.7%], OR [95%CI] = 0.95 [0.57-1.57]). Burn patients exhibited a significantly higher frequency of microbiological sampling (51.5% versus 24.5%, p < 0.001), resulting in a higher overall prevalence of bacteremia (10.2% versus 5.1%, p = 0.002). 16.2% of all identified pathogens were multidrug-resistant (MDR). The 60-day all-cause mortality was higher in patients with MDR pathogens than in patients without bacteremia (41.7% versus 10.6%, p = 0.026).

Conclusion: Bacteremia prevalence was similar in burn and non-burn patients, with high rates of multidrug-resistant Gram-negative pathogens. The 60-day all-cause mortality was significantly higher in patients with MDR pathogens than in patients without bacteremia.

Citing Articles

Enrichment of H3S28p and H3K9me2 Epigenetic Marks on Inflammatory-Associated Gene Promoters in Response to Severe Burn Injury.

Arias-Perez O, Escobedo-Tapia T, Cintora-Ahumada C, Leon-Solis L, Leyva-Garcia N, Arechaga-Ocampo E Life (Basel). 2025; 14(12.

PMID: 39768289 PMC: 11677237. DOI: 10.3390/life14121581.

References
1.
Hu Y, Li D, Xu L, Hu Y, Sang Y, Zhang G . Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study. Antimicrob Resist Infect Control. 2021; 10(1):98. PMC: 8243830. DOI: 10.1186/s13756-021-00969-w. View

2.
Raz-Pasteur A, Hussein K, Finkelstein R, Ullmann Y, Egozi D . Blood stream infections (BSI) in severe burn patients--early and late BSI: a 9-year study. Burns. 2012; 39(4):636-42. DOI: 10.1016/j.burns.2012.09.015. View

3.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

4.
Nitsani Y, Michael T, Halpern D, Hasidim A, Sher M, Givoli Vilensky R . Blood Stream Infections in Burns: A 14-Year Cohort Analysis. Life (Basel). 2023; 13(6). PMC: 10304160. DOI: 10.3390/life13061357. View

5.
Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View